CPC A61B 5/14556 (2013.01) [A61B 5/14525 (2013.01); A61B 5/4848 (2013.01); A61K 49/0021 (2013.01)] | 14 Claims |
1. A method for determining a dosing prescription for a medicament in a patient undergoing continuous renal replacement therapy (CRRT), the method comprising:
administering to the bloodstream of the patient a fluorescent agent, wherein the fluorescent agent is a compound of Formula I
![]() or a pharmaceutically acceptable salt thereof;
administering to the patient at least one dose of the medicament wherein administering the fluorescent agent and the medicament to the patient is either sequential or simultaneous;
performing CRRT on the patient after administering the fluorescent agent to the patient;
exposing the fluorescent agent to visible or infrared light, thereby causing spectral energy to emanate from the fluorescent agent;
monitoring transcutaneously a change in the spectral energy from the fluorescent agent over a period of time;
correlating a change in intensity of the spectral energy from the fluorescent agent to a clearance rate of the fluorescent agent from the bloodstream in the patient;
correlating a clearance rate of the medicament in the patient to the clearance rate of the fluorescent agent;
determining a concentration of the medicament in the bloodstream of the patient as a function of time based on the clearance rate of the fluorescent agent; and
adjusting the dosing prescription of the medicament to the patient based on the concentration of the medicament in the bloodstream of the patient as a function of time thereby determining the dosing prescription for the medicament to the patient.
|